drugset / Trial / NCT02549040
Bioavailability of Doravirine (MK-1439) Experimental Nano Formulations in Healthy Adults (MK-1439-046)
NaSingle-groupOpen-labelTreatment
Summary
This study aims to evaluate and compare the relative bioavailability of different doravirine (MK-1439) experimental nano formulations (NFs) with that of a doravirine film coated tablet.
Timeline
- Start
- 2015-09-21
- Primary completion
- 2015-12-24
- Completion
- 2015-12-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doravirine | Small molecule | 100 mg | Oral |
| Subject | Doravirine | Small molecule | 150 mg | Oral |